Vivo Ventures VI LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:28 pm Unchanged | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Ventures VI LLC | 1,383,179 5.700% | 0 (Unchanged) | Filing |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Ventures VI LLC | 1,383,179 5.900% | 360,686 (+35.28%) | Filing |
| 2020-02-13 4:30 pm Purchase | 2019-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Ventures VI LLC | 1,022,493 5.700% | 97,412 (+10.53%) | Filing |